Digital Oncology Cross Topic @ DKFZ
banner
digitaloncology.bsky.social
Digital Oncology Cross Topic @ DKFZ
@digitaloncology.bsky.social
We are Data Scientists & Architects in Cancer Research.
The German Cancer Research Center is matrix structured, with 5 research topics & cross topics. Our cross topic boosts cancer research by driving next level AI methods & data science in all domains.
Pinned
Welcome to the Cross Topic for Digital Oncology @dkfz.bsky.social!
We're home to >350 data scientists. By uniting data science & cancer research, we address critical infrastructure & methodological needs to shape the future of #AI in #medicine💡
#DigitalOncology #CancerResearch #DataScience
Two of the world’s most highly cited researchers are affiliated with the Digital Oncology Cross Topic - congratulations to @oliverstegle.bsky.social & Florian Büttner!
Check out the full list here: clarivate.com/highly-cited...
November 13, 2025 at 3:27 PM
Reposted by Digital Oncology Cross Topic @ DKFZ
How the biological clock ticks in the female reproductive tract - Breakthrough of the Year Award 2025 for Ângela Gonçalves 👏
@afilimon.bsky.social
#FallingWalls #ScienceSummit25

t1p.de/8fbxy
How the biological clock ticks in the female reproductive tract - Breakthrough of the Year Award 2025 for Ângela Gonçalves
Endometriosis, menopause, ovarian cancer – still poorly researched and often misdiagnosed. Ângela Gonçalves combines AI, molecular biology, and clinical findings to develop non-invasive tools for earl...
t1p.de
November 7, 2025 at 10:23 AM
Exciting new framework from the Stegle group, built together with Florian Büttner’s lab - great example of how our close ties within the Digital Oncology network foster innovation!
Are you using any of our factor models, such as MOFA? 🛵
You might’ve found it challenging to tailor them to your specific use cases - not anymore!

Introducing MOFA-FLEX: a flexible, modular factor analysis framework designed for customizable modeling across diverse multi-omics data scenarios. 1/n
November 7, 2025 at 1:05 PM
Reposted by Digital Oncology Cross Topic @ DKFZ
Thrilled to welcome Jonas Huebotter (ETH Zurich) to our heidelberg.ai seminar series. He will guide us through the world of test-time training in which the model is adapted for each new input during the prediction phase - unlocking powerful new applications!
Sign up: www.meetup.com/heidelberg-a...
October 24, 2025 at 12:11 PM
Reposted by Digital Oncology Cross Topic @ DKFZ
Honored to host Stanford Professor Dr. Curtis Langlotz in the NCT Data Science Seminar! This is a great opportunity to hear from one of the most influential voices shaping the future of medical AI, developing ML methods to detect disease & eliminate diagnostic errors.
Register here: lnkd.in/eJDwtBU9
September 25, 2025 at 3:05 PM
Reposted by Digital Oncology Cross Topic @ DKFZ
We’re thrilled to welcome Yuki Asano, Professor at the University of Technology Nuremberg and head of the Fundamental AI (FunAI) Lab, to our heidelberg.ai / NCT Data Science Seminar series on May 13th at 5 pm in Heidelberg (INF280 Seminar Rooms K1+K2) for an in-person event.
April 27, 2025 at 9:44 AM
🚠 #AI in Altitude - a high-flying start for Digital Oncology@DKFZ with NCT & DKTK partners!
We gathered at the scenic Königstuhl for a retreat packed with energy, ideas & collaboration. From AI for data management to a translation task force, lots of science & strategy: excited for what’s ahead!💡🧠💻
April 11, 2025 at 2:53 PM
Ready to turn vision into reality! ✅ Our 5 key pillars are set to add value to #DKFZ & the wider #DataScience community. By focusing on community, capacity-building, infrastructures, building bridges, and applying #AI in targeted domains, we're paving the way for #innovation and #collaboration 🚀
March 21, 2025 at 9:52 AM
Welcome to the Cross Topic for Digital Oncology @dkfz.bsky.social!
We're home to >350 data scientists. By uniting data science & cancer research, we address critical infrastructure & methodological needs to shape the future of #AI in #medicine💡
#DigitalOncology #CancerResearch #DataScience
March 20, 2025 at 1:21 PM